Sign in
Taking people in United StatesNo phase

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

Key facts

Who runs it
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Recruiting
People taking part
3 people, planned
Started
7 Feb 2022
Expected to end
Jan 2030
Type of study
Interventional
Treatments tested
  • DBS of the NAc
Record updated
31 August 2026

Who can take part

Age
22 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Male and females age ≥ 22 years with diagnosis of opioid use disorder (OUD) based on Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) with at least a 5-year history
  • OUD must be the primary disorder
  • History of ongoing or previous opioid use, relapse, and/or cravings, despite attempts at, or attendance in, at least two different treatment modalities. These modalities may include: Comprehensive Opioid Addiction Treatment (COAT), intensive outpatient COAT, residential treatment, inpatient treatment, alternative to intensive outpatient programs, Drug Dependence Unit programs, medication-assisted treatment (MAT), medication assisted recovery (MAR), inpatient or outpatient rehabilitation, detox programs, Narcotics Anonymous, individual or group therapy, Partial Hospitalization Programs (PHP), Sober living homes, or similar interventions
  • Self-reports ongoing opioid cravings
  • Has completed a neuro-psychological evaluation to the satisfaction of a neuropsychologist
  • Has completed a psychiatric evaluation to the satisfaction of a psychiatrist
  • Has had a brain MRI performed and reviewed by neurosurgeon with no contraindication for DBS procedure identified
  • Platelet count > 125,000 per cubic mm and prothrombin time (PT) and partial thromboplastin time (PTT) within normal limits
  • Negative blood cultures to rule out bacteremia

Who cannot take part

  • Prior brain surgery contraindicating Deep Brain Stimulation (DBS) surgery, including procedures that required a craniotomy (e.g., brain tumor removal, trauma or pressure relief, hemorrhage, or clot evacuation). Patients with other brain surgery history will be considered and approved at the discretion of the Principal Investigator (PI)
  • History of uncontrolled or persistent seizures
  • Suspected dementia based on neuropsychological screening or Mini Mental State Exam (MMSE) Score < 25
  • Diagnosis of neurological disorders (e.g. multiple sclerosis, Parkinson's disease, and stroke)
  • Have any other medical condition that, in the opinion of the Investigator, makes the subject unsuitable for enrollment
  • Coagulopathy secondary to chronic need for anticoagulation medicine (e.g. warfarin) or anti-platelet medication (e.g. aspirin or clopidogrel)
  • Baseline assessment on the Hamilton Depression Rating Scale (HAMD) of greater than 17 or moderate risk of suicide based upon a score of 3 or greater on the Columbia Suicide Severity Scale, unless clinical judgment indicates that the individual is appropriate for inclusion despite these scores
  • Contraindications for MRI:; Presence of implanted electrical stimulation device or other implanted metal devices (excluding dental braces); Claustrophobia; Body weight exceeding limit of the machine (180 kg/400 lb)
  • Females who are pregnant or nursing. Female subjects of child-bearing potential must have a negative pregnancy test during the pre-op phase and must agree to utilize adequate birth control throughout the trial and for at least 30 days following trial completion
  • Severe brain atrophy or presence of subdural hygromas or subdural hematomas on brain MRI
  • Any evidence of underlying endocarditis
  • Primary language other than English

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 22 and 65 years old?

Where in United States

  • AHN Allegheny General HospitalPittsburgh, United StatesContact: Nestor Tomycz, MD (principal investigator)Taking people

About the trial

What the trial wants to find out

This is a pilot study to evaluate the safety and efficacy of deep brain stimulation (DBS) of the nucleus accumbens (NAc) as adjunctive treatment for treatment-refractory opioid use disorder. This study will include 3 individuals with opioid use disorder and relapsing opioid use despite active participation in a drug addiction treatment program.

The group in the trial

  • NAc DBSTreatment being tested

    Subjects will receive bilateral DBS of the NAc

    Treatment: DBS of the NAc

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Pilot Study to Evaluate Deep Brain Stimulation (DBS) of the Nucleus Accumbens (NAc) for Patients With Treatment-refractory Opioid Use Disorder
Fit questions
Built from NCT04354077, who can take part
Record updated
31 August 2026